First Time Loading...

Lihit Lab Inc
TSE:7975

Watchlist Manager
Lihit Lab Inc Logo
Lihit Lab Inc
TSE:7975
Watchlist
Price: 1 168 JPY -0.6% Market Closed
Updated: Jun 11, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

13.1B
-1%
Assets
Growth Rates:
1 Year
+3%
3 Years
+2%
5 Years
-2%
7 Years
+0%
10 Years
0%
2.9B
-5%
Liabilities
Growth Rates:
1 Year
+14%
3 Years
-11%
5 Years
-30%
7 Years
-34%
10 Years
-38%
10.2B
-0.3%
Equity
Growth Rates:
1 Year
+0%
3 Years
+6%
5 Years
+10%
7 Years
+18%
10 Years
+20%

Balance Sheet Decomposition
Lihit Lab Inc

13.1B
Assets
2.9B
Liabilities
13.1B
Assets
2.9B
Liabilities
Current Assets 5.7B
Cash & Short-Term Investments 1.2B
Receivables 1.7B
Other Current Assets 2.8B
Non-Current Assets 7.4B
Long-Term Investments 1.1B
PP&E 5.8B
Intangibles 40.8m
Other Non-Current Assets 442.4m
Current Liabilities 1.1B
Accounts Payable 192.2m
Accrued Liabilities 159.7m
Other Current Liabilities 728.7m
Non-Current Liabilities 1.8B
Long-Term Debt 437.5m
Other Non-Current Liabilities 1.4B

Balance Sheet
Lihit Lab Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Feb-2015 Feb-2016 Feb-2017 Feb-2018 Feb-2019 Feb-2020 Feb-2021 Feb-2022 Feb-2023 Feb-2024
Assets
Cash & Cash Equivalents
825
1 024
1 274
1 841
1 272
1 679
1 798
2 260
1 077
1 243
Cash Equivalents
825
1 024
1 274
1 841
1 272
1 679
1 798
2 260
1 077
1 243
Total Receivables
1 822
1 860
2 089
2 068
1 997
2 025
1 885
1 651
1 766
1 729
Accounts Receivables
1 822
1 860
2 089
2 068
1 997
2 025
1 885
1 651
1 551
1 510
Other Receivables
0
0
0
0
0
0
0
0
215
219
Inventory
2 518
2 674
2 332
2 317
2 701
2 428
2 401
2 514
2 840
2 555
Other Current Assets
198
168
104
142
111
80
72
125
342
220
Total Current Assets
5 362
5 727
5 798
6 367
6 080
6 212
6 156
6 550
6 025
5 746
PP&E Net
6 432
6 165
5 849
5 603
5 830
5 758
5 529
5 360
5 208
5 810
Intangible Assets
51
43
37
26
27
18
15
19
16
41
Note Receivable
20
2
2
2
1
1
0
0
0
0
Long-Term Investments
900
906
1 019
1 243
1 055
814
798
1 036
1 097
1 078
Other Long-Term Assets
396
398
364
396
402
390
369
365
387
442
Total Assets
13 150
N/A
13 241
+1%
13 070
-1%
13 636
+4%
13 396
-2%
13 193
-2%
12 867
-2%
13 330
+4%
12 732
-4%
13 118
+3%
Liabilities
Accounts Payable
823
1 019
985
1 062
741
607
523
482
186
192
Accrued Liabilities
126
119
131
138
149
150
122
119
150
160
Short-Term Debt
270
0
0
70
0
0
0
0
0
0
Current Portion of Long-Term Debt
259
789
1 106
259
299
610
227
253
130
314
Other Current Liabilities
487
388
504
758
531
473
467
458
319
415
Total Current Liabilities
1 965
2 315
2 726
2 287
1 721
1 840
1 338
1 311
785
1 081
Long-Term Debt
916
784
35
761
929
600
593
514
370
438
Deferred Income Tax
203
170
197
261
169
90
108
211
225
241
Other Liabilities
1 468
1 477
1 431
1 294
1 283
1 264
1 203
1 183
1 132
1 116
Total Liabilities
4 552
N/A
4 746
+4%
4 388
-8%
4 603
+5%
4 101
-11%
3 795
-7%
3 243
-15%
3 219
-1%
2 512
-22%
2 875
+14%
Equity
Common Stock
1 830
1 830
1 830
1 830
1 830
1 830
1 830
1 830
1 830
1 830
Retained Earnings
5 364
5 223
5 349
5 576
5 943
6 178
6 447
6 624
6 521
6 343
Additional Paid In Capital
1 412
1 412
1 412
1 412
1 412
1 412
1 412
1 412
1 412
1 412
Unrealized Security Profit/Loss
339
361
448
603
472
304
293
457
499
538
Treasury Stock
398
399
400
400
401
401
401
401
401
402
Other Equity
51
68
42
13
38
75
44
189
360
521
Total Equity
8 598
N/A
8 495
-1%
8 681
+2%
9 034
+4%
9 294
+3%
9 398
+1%
9 624
+2%
10 110
+5%
10 220
+1%
10 242
+0%
Total Liabilities & Equity
13 150
N/A
13 241
+1%
13 070
-1%
13 636
+4%
13 396
-2%
13 193
-2%
12 867
-2%
13 330
+4%
12 732
-4%
13 118
+3%
Shares Outstanding
Common Shares Outstanding
2
2
3
3
3
3
3
3
3
3

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 146,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.